Figure 3. Footpad lesion size in BALB/c at 45 days post-infection following vaccination with SLAgs + pristane and challenge with L. major. Results presented as mean ± SD

From

Soluble Leishmania Antigens Plus Pristane Adjuvant Induce Partial Cross-protection Against Leishmaniasis in BALB/c mice

Byrum Wabwoba, Damaris Matoke-Muhia, Johnston Ingonga, Japheth Lusweti, Michael Gicheru

American Journal of Infectious Diseases and Microbiology. 2025, 13(1), 26-31 doi:10.12691/ajidm-13-1-4